Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations.
Allison Lipitz-SnydermanSusan ChimonasSham MailankodyMichelle KimNicholas SilvaAnuja KriplaniLeonard B SaltzSmita SihagCarlyn Rose TanMaria WidmarMarjorie G ZaudererSaul N WeingartWendy PerchickBenjamin R RomanPublished in: Cancer medicine (2023)
Second-opinion consultations sometimes add clinical value by improving expected prognoses; more often, they offer treatment de-escalations, with corresponding reductions in expected short- and/or long-term morbidity. Future research could identify subgroups of patients most likely to benefit from second opinions.